CLINICAL TRIALS PROFILE FOR ADAKVEO
✉ Email this page to a colleague
All Clinical Trials for ADAKVEO
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT04611880 ↗ | Crizanlizumab for Treatment of Retinal Vasculopathy With Cerebral Leukoencephalopathy (RVCL) | Recruiting | Washington University School of Medicine | Phase 2 | 2021-01-25 | This is a Phase 2 trial that will test the efficacy and safety of crizanlizumab for the treatment of retinal vasculopathy with cerebral leukoencephalopathy (RVCL), a very rare and uniformly fatal genetic condition that affects the microvasculature, especially of the brain and eye. There currently is no treatment for RVCL. A maximum of 20 patients will be enrolled. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for ADAKVEO
Condition Name
Clinical Trial Locations for ADAKVEO
Trials by Country
Clinical Trial Progress for ADAKVEO
Clinical Trial Phase
Clinical Trial Sponsors for ADAKVEO
Sponsor Name